Parenteral Combination Therapy For Infective Conditions With Drug Resistant Bacterium
AssigneeVenus Remedies Limited
InventorManu Chaudhary
Life of this patent
Estimating the term…
Loading patent…
AssigneeVenus Remedies Limited
InventorManu Chaudhary
Estimating the term…
The invention describes a pharmaceutical composition to combat multiple-drug-resistant bacteria in non-ocular infective conditions. Compositions comprising glycopeptides, in particular vancomycin, and cephalosporins, in particular ceftriaxone, are disclosed. Such compositions are found to be useful for parenteral administration for hospitalized patients with serious infections. Specifically, this invention also discloses a pharmaceutical composition further including an excipient such as CVMC agent and is available in dry powder form for reconstitution before injection with a suitable solvent. The pharmaceutical compositions of this invention have been found normally to enhance resistance to precipitation in solutions to be administered parenterally. The invention also gives details of the dosage forms stored in sealed containers to be reconstituted before use. The invention further provides a process to manufacture these compositions and also a method of treating a subject having non-ocular infective conditions due to multi drug resistant bacterium.
A parenteral combination therapy for non-ocular infective conditions with drug resistant bacterium, comprising a pharmaceutical composition, comprising:
A process for preparing a pharmaceutical composition suitable for parenteral combination therapy for non-ocular infective conditions with drug resistant bacterium, comprising the steps of:
A pharmaceutical composition suitable for parenteral combination therapy for non-ocular infective condition with drug resistant bacterium substantially as herein described and illustrated.
A process for preparing a pharmaceutical composition suitable for parenteral combination therapy for non-ocular infective conditions with drug resistant bacterium substantially as herein described and illustrated.
A method of treatment and/or prevention of a non-ocular infective condition caused by drug resistant bacterium, substantially as herein described and illustrated.
Dependencies are inferred from the claim text.